首页> 外文期刊>Journal of thrombosis and thrombolysis >Family history of venous thromboembolism and mortality after venous thromboembolism: a Swedish population-based cohort study
【24h】

Family history of venous thromboembolism and mortality after venous thromboembolism: a Swedish population-based cohort study

机译:静脉血栓栓塞和静脉血栓栓塞后的静脉血栓栓塞和死亡的家族史:瑞典人群队列队列研究

获取原文
获取原文并翻译 | 示例
           

摘要

Studies on whether family history (FH) of venous thromboembolism (VTE) affects long-term mortality after VTE are missing. The aim of this study was to determine whether FH of VTE affects long-term mortality after a first episode of VTE. Using Swedish medical databases, we conducted a 30-year nationwide cohort study of 49,159 adult Swedish born patients included in the multi-generation register (born 1932 or later) with a first-time VTE (1981-2010). Using Cox regression, we assessed mortality Hazard ratios (HRs) with 95% confidence intervals (CIs). Totally 10,093 (20.5%) patients with VTE had a first-degree FH of VTE (parent/sibling). Patients without FH of VTE had significantly more VTE provoking risk factors and comorbidities than those with FH. The mortality HR the first 10-years after first time VTE was decreased for those with FH of VTE compared to for those without FH: crude HR 0.807, 95% CI 0.771-0.845 and adjusted HR 0.864, 95% CI 0.826-0.905. After 10-years of follow-up there was no significant effect of FH of VTE on mortality: crude HR = 1.018, 95% CI 0.905-1.145 and adjusted HR = 0.995, 95% CI 0.884-1.119. Cancer-associated mortality was more common in those without FH the first 10 years (56.9 vs. 53.4%, p = 0.002). After 10 years there were no difference in cancer-associated mortality (4.9 vs. 5.6%, p = 0.604). The results suggest that patients with FH of VTE have lower thrombotic threshold and need less provoking factors and comorbidities. They have also slightly lower total and cancer mortality the first 10 years after VTE.
机译:静脉血栓栓塞(VTE)的家族史(FH)对VTE缺失后影响长期死亡率的研究。本研究的目的是确定VTE的FH是否会影响VTE第一集后的长期死亡率。使用瑞典医疗数据库,我们在多代寄存器(1932或更高版本)的49,159名成人瑞典患者中进行了30年的全国范围的队列研究,其中包括第一次vte(1981-2010)。使用COX回归,我们评估了95%置信区间(CIS)的死亡率危害比率(HRS)。 vte的总共10,093名(20.5%)的患者具有VTE的一级FH(父母/兄弟姐妹)。没有FH的VTE的患者显着引起危险因素和合并症的患者比FH。与VTE的FH的第一次vte的前10年后的死亡率HR与没有FH的那些,粗糙HR 0.807,95%CI 0.771-0.845和调整后的HR 0.864,95%CI 0.826-0.905。 10年后的后续后,VTE对死亡率的FH没有显着影响:粗糙HR = 1.018,95%CI 0.905-1.145和调整的HR = 0.995,95%CI 0.884-1.119。在没有FH的情况下,癌症相关的死亡率更常见(56.9 vs.53.4%,p = 0.002)。 10年后,癌症相关死亡率没有差异(4.9 vs.5.6%,P = 0.604)。结果表明,VTE FH的患者具有较低的血栓形成阈值,需要较少的引人注目的因子和合并症。在VTE后的前10年,它们也略低了总数和癌症死亡率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号